Similar Articles |
|
HHMI Bulletin Nov 2010 |
Scientists are targeting surface proteins to battle disease. Now that genomic analyses have identified the genes that express surface proteins, scientists are focusing on how pathogens detect attacks from the human immune system and quickly change their coats. |
Chemistry World June 17, 2015 James Urquhart |
Promising compound offers single dose knock-out for malaria Ian Gilbert and colleagues, working with the Medicines for Malaria Venture, have found a compound dubbed DDD107498 which kills Plasmodium falciparum -- the species responsible for most dangerous form of malaria. |
Chemistry World March 21, 2013 Phillip Broadwith |
New antimalarial drug class resists resistance Early indications also show that it may take longer for the parasite to develop resistance to the new molecules than it has for existing drugs targeting the same pathway. |
Chemistry World April 9, 2009 Phillip Broadwith |
Dual-action malaria drug reverses resistance US chemists have designed a new class of antimalarial drug that can reverse the malaria parasite's resistance to existing drugs. |
Chemistry World April 2008 Victoria Gill |
Malaria no More? A fresh round of research funding could put an end to the killer disease. |
Chemistry World July 23, 2013 Sonja Hampel |
Antigenic sugars identified for Chagas disease Scientists have synthesised the combinations of sugars from the surface of the Chagas disease parasite that trigger the human immune response to it. This could help establish better diagnostic tests for the disease, and even a vaccine. |
IDB America October 2006 Alexandra Russell-Bitting |
Argentine Laboratory Tracks a Killer A new University of Buenos Aires laboratory is addressing one of the neglected diseases the Pan American Health Organization describes as "stigmatizing diseases of poverty that can only be tackled by leadership and a concerted political and economic effort." |
CIO October 15, 2001 Stephanie Overby |
Drug Companies on speed The marriage of IT and medical research may be just what traditional pharmaceutical companies need to survive in an increasingly competitive field. Learn how IT is bringing the pharmaceutical industry into the information age... |
AskMen.com Dustin Driver |
Travel Diseases: Africa The allure of a safari through the Serengeti or a trek up Kilimanjaro may inspire you to strike out for the heart of Africa, but before you go there are a few things you should know: like, the huge continent is teeming with bug-borne, water-borne and human-borne diseases. |
Chemistry World October 27, 2010 Manisha Lalloo |
Pepper plant provides drug hope Researchers have found potential new treatments for the tropical disease leishmaniasis, by isolating compounds from a pepper plant used by Peru's native Chayahuitas people as an anti inflammatory. |
Chemistry World March 2011 |
Column: In the pipeline Drug discovery is an inherently risky business. Derek Lowe tries to balance some of the risk equations |
Chemistry World March 22, 2011 Amaya Camara-Campos |
Microfluidics to diagnose sleeping sickness Jonas Tegenfeldt from the University of Lund developed a microfluidic device that separates the parasites in this disease from the blood cells using their shape, because parasites and red blood cells are very difficult to separate by size. |
HHMI Bulletin May 2010 Kendall Powell |
Malaria's Weakness With different approaches, two HHMI researchers land on an enzyme critical to the malaria parasite's destructive ways. |
AskMen.com Joshua Levine |
Selling Your Body To Science Have you ever thought about the number of voluntary patients who basically sell their bodies to clinical trials in the name of science? Well, the number is staggering and it can reach well into the thousands. The main reason being the large paycheck that comes with the job. |
Bio-IT World July 11, 2002 Kevin Davies |
Counting the Cost of Drug Discovery Much of the trouble ensnaring the drug industry is blamed on the exorbitant cost of drug discovery. Tangible proof that the bio-IT revolution will economize drug discovery is emerging, but there is still a long way to go. |
Chemistry World September 10, 2007 Lewis Brindley |
Taking the Sting Out of Malaria Scientists have identified sugar chains lining the mosquito's gut that the malaria parasite latches onto to infect the insect. |
The Motley Fool January 26, 2005 Stephen D. Simpson |
The Pipeline to Biotech Success Looking at drug R&D is the best way to begin assessing biotech companies as possible investment opportunities. |
Chemistry World November 11, 2014 Charlie Quigg |
Sleeping sickness fly trap in a nutshell An international team of chemists has developed a green method for creating odour attractants to trap the insects that spread African sleeping sickness. |
Investment Advisor December 2005 Greg B. Scott |
Buying The Future Prudent investing in biotechnology can offer great returns for clients. It's also the wave of the future. Armed with a basic understanding of the dynamics of the industry and the valuation inflection points, intelligent investors can make significant returns. |
The Motley Fool May 28, 2004 Charly Travers |
Don't Be a Biotech Gambler Stand on solid ground by learning to assess the value of future drug programs. Investing in biotechs -- rather than simply speculating in the sector -- requires a solid assessment of how much a company's drug programs could be worth. |
Managed Care June 2005 John Carroll |
UnitedHealth Stakes Claims On New Drug Safety Program One of the nation's largest health insurers will analyze claims to discover unintended effects of new drugs on its members. |
Chemistry World December 2009 |
Column: In the pipeline Is the pharmaceutical industry churning out copycat versions of existing therapies? The author dispels a few myths about 'me-too' drugs |
The Motley Fool August 2, 2004 Charly Travers |
What's a Drug Worth? The value of small biotech companies is in their investigational drug programs. |
Managed Care March 2000 Steve Heimoff |
Getting Out From Under Drug Companies' Shadows The perception that disease management is merely a drug marketing tool seems finally to have vanished from this healthy, though fragmented, industry. |
AskMen.com Dustin Driver |
Sleeping Pills You have a lot of options when it comes to sleeping pills. Take a look at this list of some of the most commonly prescribed sleeping pills before you make any decisions. |
Pharmaceutical Executive July 30, 2007 Louis A. Morris |
Safety Net The new Culture of Drug Safety means embracing the benefit of no doubt about a product's pluses and its minuses. Pharma must learn how patients and prescribers weigh risks and how to spread the word about the advantages. |
The Motley Fool November 15, 2007 Charly Travers |
John Edwards, Frozen Caveman Lawyer Presidential hopeful John Edwards' health-care plans could destroy drug research and development in this country by removing the patent protection on breakthrough drugs. |
Salon.com September 26, 2000 Jill Wolfson |
You're an excellent host Parasites can slip into your body, rewrite your DNA and, sometimes, change your mood. Science writer Carl Zimmer's new book, "Parasite Rex: Inside the Bizarre World of Nature's Most Dangerous Creatures," introduces readers to some of nature's most sinister characters... |